Increased levels of FGF19 are observed with the downregulation of miR-520e, which leads to the stabilization of β-catenin and the activation of the Wnt/β-catenin pathway, driving glioma cell proliferation and invasion. The gene discussed is FGF19; the disease is central nervous system cancer.